These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4010375)

  • 21. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive and active immunoprophylaxis of hepatitis B.
    Seeff LB; Koff RS
    Gastroenterology; 1984 May; 86(5 Pt 1):958-81. PubMed ID: 6231210
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody response to hepatitis B virus vaccine.
    Ozsoylu S
    J Pediatr Gastroenterol Nutr; 1987; 6(6):998-9. PubMed ID: 3681590
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-term observation on the immunogenicity of hepatitis B vaccine in infants and adults].
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H; Shingu T
    Kansenshogaku Zasshi; 1986 Jul; 60(7):659-65. PubMed ID: 3097205
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of active preventive vaccination against hepatitis B with a German vaccine].
    Henning H; Laufs R; Kätzner K; Bredehorst R
    Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Active immunoprophylaxis of type B viral hepatitis].
    Spiga L; Mela GS
    G Clin Med; 1984; 65(5-6):237-49. PubMed ID: 6236122
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Induction of HBs antibodies using a new genetically engineered vaccine].
    Just M; Berger R; Wegmann A; Glück R
    Schweiz Rundsch Med Prax; 1988 Dec; 77(51):1407-9. PubMed ID: 2975822
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intracutaneous hepatitis B vaccination].
    van Houte DP; Vroom TM
    Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1237-40. PubMed ID: 4022172
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of hepatitis B by vaccination].
    Degré M; Siebke JC; Frøland SS
    Tidsskr Nor Laegeforen; 1984 Sep; 104(27):1906-7. PubMed ID: 6515608
    [No Abstract]   [Full Text] [Related]  

  • 32. [Screening for hepatitis B].
    Krogsgaard K
    Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
    [No Abstract]   [Full Text] [Related]  

  • 33. The first identified hepatitis B virus vaccine escape mutation in Turkey.
    Kutlu T; Soycan LY; Karatayli E; Türkyilmaz AR; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2006 Feb; 35(2):201-2. PubMed ID: 16230046
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of passively administered antibody to hepatitis B surface antigen to augment the immune response of a low-responder population to hepatitis B vaccination.
    Minuk GY; German GB; Bernstein KN; Fine A; Schroeder ML; Wong WW
    Clin Invest Med; 1994 Feb; 17(1):61-5. PubMed ID: 8174316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results.
    Berthelot P; Courouce AM; Eyquem A; Feldmann G; Jacob J; Ravisse P; Vacher B; Moor-Jankowski J; Muchmore E; Prince A
    J Med Primatol; 1984; 13(3):119-33. PubMed ID: 6239039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune status of various populations to hepatitis B virus in Singapore and a strategy for its prevention and immunoprophylaxis.
    Ha CS; Ngoh GC; HA CS; Ngoh GC; Tai GK; Lim C; Keow LG; Wan OY; Hock QS; Leong TK
    Dev Biol Stand; 1983; 54():295-305. PubMed ID: 6653887
    [No Abstract]   [Full Text] [Related]  

  • 38. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
    Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
    J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.
    Fitzsimons D; François G; Hall A; McMahon B; Meheus A; Zanetti A; Duval B; Jilg W; Böcher WO; Lu SN; Akarca U; Lavanchy D; Goldstein S; Banatvala J; Damme PV
    Vaccine; 2005 Jul; 23(32):4158-66. PubMed ID: 15964484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis A and B booster recommendations: implications for travelers.
    Zuckerman JN; Connor BA; von Sonnenburg F
    Clin Infect Dis; 2005 Oct; 41(7):1020-6. PubMed ID: 16142669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.